Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 43204 gel for field treatment of actinic keratosis on balding scalp
2015-002451-10Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Apr 2016
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ingenol disoxate in actinic keratosis (AK), sponsored by LEO Pharma. Primary endpoint: Complete clearance at Week 8. Started Apr 2016; status: completed.
02
Drugs
ingenol disoxate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2015-002451-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002451-10.